Related references
Note: Only part of the references are listed.Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β2-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosis
Charis Pericleous et al.
RHEUMATOLOGY (2015)
14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends
Maria Laura Bertolaccini et al.
AUTOIMMUNITY REVIEWS (2014)
The Mosaic of Seronegative Antiphospholipid Syndrome
Fabrizio Conti et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called 'seronegative APS')
Jose Luis Rodriguez-Garcia et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Does seronegative antiphospholipid syndrome really exist?
Ricard Cervera et al.
AUTOIMMUNITY REVIEWS (2012)
Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome
Elena Ortona et al.
BLOOD (2010)
In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of β2-glycoprotein I: proof of concept
Y. Ioannou et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study
B. De Laat et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I - Mutation studies including residues R39 to R43
Yiannis Ioannou et al.
ARTHRITIS AND RHEUMATISM (2007)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Share Paper
